Replimune (REPL) Return on Invested Capital (2023 - 2026)
Replimune (REPL) reported Return on Invested Capital of 0.03% for Q1 2026, down 1.0% on a YoY basis from 0.03% in Q1 2025, and up 1.21% sequentially from 0.03% in Q4 2025.
Replimune (REPL) Return on Invested Capital (2023 - 2026) Analysis & Trends
Replimune (REPL) has 4 years of Return on Invested Capital data on file, last reported at 0.03% in Q1 2026.
- For the quarter ending Q1 2026, Return on Invested Capital fell 1.0% year-over-year to 0.03%; the trailing twelve-month figure through Mar 2026 stood at 0.03% (down 1.0% YoY), and the FY2026 full-year result was 0.13%, down 3.0% from the prior year.
- Return on Invested Capital rose to 0.03% in Q1 2026, from 0.03% in the prior quarter.
- In the past five years, Return on Invested Capital ranged from a high of 0.02% in Q1 2023 to a low of 0.03% in Q4 2025.
- A 4-year average of 0.02% and a median of 0.02% in 2024 frame the typical range for Return on Invested Capital.
- Peak annual rise in Return on Invested Capital reached 0 bps in 2024, while the deepest fall reached 1 bps in 2024.
- Tracing REPL's Return on Invested Capital over 4 years: stood at 0.02% in 2023, then slipped by 7 bps to 0.02% in 2024, then plunged by 38 bps to 0.03% in 2025, then rose by 1 bps to 0.03% in 2026.
- Business Quant data shows REPL's Return on Invested Capital at 0.03% in Q1 2026, 0.03% in Q4 2025, and 0.03% in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROIC (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 0.00% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 0.04% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Replimune | 970.73 Mn | 970.73 Mn | - | -0.03% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.03% |
| Dec 31, 2025 | -0.03% |
| Mar 31, 2025 | -0.03% |
| Dec 31, 2024 | -0.02% |
| Sep 30, 2024 | -0.02% |
| Jun 30, 2024 | -0.02% |
| Mar 31, 2024 | -0.02% |
| Dec 31, 2023 | -0.02% |
| Sep 30, 2023 | -0.02% |
| Jun 30, 2023 | -0.02% |
| Mar 31, 2023 | -0.02% |